Drug recall
Red Blood Cells (Apheresis)
FDA recall event 38985 · Class III · Central Blood Bank
Key facts
| Event ID | 38985 |
|---|---|
| Recall numbers | B-0345-08 |
| Recalling firm | Central Blood Bank |
| Product type | Biologics |
| Products | Red Blood Cells (Apheresis) |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, associated with a red cell component that contained clots, was distributed. |
| Initiation date | May 30, 2007 |
| Termination date | Nov 28, 2007 |
| City | Pittsburgh |
| State | PA |
| Country | United States |
| FEI number | 2571073 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports